Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 126 of 200 Β· By data quality, then INN

  1. gozetotide

    LOCAMETZ

    EMA: approved

    V09I
  2. gusperimus

    SPANIDIN

    EMA: application withdrawn

  3. haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine

    PROCOMVAX

    EMA: unknown

    J07CA
  4. hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)

    AMBIRIX

    EMA: approved

    J07BC20
  5. hepatitis b (rdna) vaccine (adjuvanted, adsorbed)

    FENDRIX

    EMA: approved

    J07BC01
  6. hepatitis b surface antigen

    HEPLISAV B

    EMA: approved

    J07BC01
  7. hepatitis b surface antigens recombinant (s, pre-s1, pre-s2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (c127i) cells]

    HEPACARE

    EMA: withdrawn

    J07BC
  8. hepatitis b vaccine (recombinant dna)

    HBVAXPRO

    EMA: approved

    J07BC01
  9. herpes zoster vaccine (recombinant, adjuvanted)

    SHINGRIX

    EMA: approved

    J07BK03
  10. histamine dihydrochloride

    CEPLENE

    EMA: approved Β· PMDA: approved

    L03AX14
  11. human coagulation factor ix

    NONAFACT

    EMA: withdrawn

    B02BD04
  12. human coagulation factor viii / human von willebrand factor

    VONCENTO

    EMA: approved

    B02BD06
  13. human coagulation factor x

    COAGADEX

    EMA: approved

    B02BD13
  14. human hepatitis b immunoglobulin

    ZUTECTRA

    EMA: approved

    J06BB04
  15. human heterologous liver cells

    HEPARESC

    EMA: refused

    A16
  16. human insulin (rdna)

    ACTRAPID

    EMA: approved

    A10AB01
  17. human normal immunoglobulin (ivig)

    PRIVIGEN

    EMA: approved

    J06BA02
  18. human normal immunoglobulin (scig)

    HIZENTRA

    EMA: approved

    J06BA01
  19. human papillomavirus 9-valent vaccine (recombinant, adsorbed)

    GARDASIL 9

    EMA: approved

    J07BM03
  20. human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)

    CERVARIX

    EMA: approved

    J07BM02
  21. human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)

    GARDASIL

    EMA: approved

    J07BM01
  22. hydroxycarbamide

    HYDREA

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01XX05
  23. ibalizumab

    TROGARZO

    EMA: withdrawn

    J05AX
  24. idebenone

    RAXONE

    EMA: approved

    N06BX13

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.